Charlotte Dyring
Fondateur chez ExpreS2ion Biotechnologies ApS
Provenance du réseau au premier degré de Charlotte Dyring
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Technical University of Denmark
53
| College/University | Other Consumer Services | 53 |
| Public Company | Biotechnology | 8 | |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark.
6
| Subsidiary | Biotechnology | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Charlotte Dyring via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Masters Business Admin Director/Board Member Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Confederation of Danish Industry
 Confederation of Danish Industry Miscellaneous Commercial ServicesCommercial Services Confederation of Danish Industry operates as a business and employers organization for small and medium-sized enterprises. It serves manufacturing industry as well as sectors such as transportation, energy, information technology, health, trade, and professional services. The firm specializes in negotiation of collective agreements with labor unions; local, national, and international business regulations; and support for members on numerous services and relevant networks. The company is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Chairman Corporate Officer/Principal Chairman | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| DANSKE BANK A/S | Major Banks | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
MT Højgaard A/S
 MT Højgaard A/S Engineering & ConstructionIndustrial Services MT Højgaard A/S provide building, civil engineering and construction services. It operates through four business areas such as civil works, construction, utility services and refurbishment. The firm serves in the area of constructing roads, bridges, harbours, shell structures, steel structures, prefabricated construction and concrete renovation for the public and private sectors. The company was founded in May 2001 and is headquartered in Soborg, Denmark. | Engineering & Construction | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer | |
| Adaptvac ApS | Director/Board Member Director/Board Member Chief Executive Officer | ||
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
LEGO A/S
 LEGO A/S Recreational ProductsConsumer Durables LEGO A/S manufactures and markets play materials and toys. The firm offers preschool products, such as loose bricks, play themes, and educational toys for kindergarten toddlers, schoolchildren and teenagers. The company was founded by Ole Kirk Kristiansen in 1932 and is headquartered in Billund, Denmark. | Recreational Products | Chief Executive Officer Director/Board Member | |
| DEMANT A/S | Medical Specialties | Chairman Chief Executive Officer | |
| KØBENHAVNS LUFTHAVNE A/S | Other Transportation | Corporate Officer/Principal Chief Executive Officer | |
VP Securities A/S
 VP Securities A/S Investment Banks/BrokersFinance VP Securities A/S offers solutions and expertise in the field of securities and investor administration. It is a financial services company that provides of securities and investor services in Denmark and offer services globally. It is an approved Central Securities Depository (CSD) in Denmark and Luxembourg, providing access to a long line of international markets to clients via collaboration with other securities depositories. It also offers package of advisory services, support, and software tools for investor relations management. The company was founded in 1980 and is headquartered in Copenhagen, Denmark. | Investment Banks/Brokers | Chief Tech/Sci/R&D Officer Director/Board Member | |
WDH Germany GmbH
 WDH Germany GmbH Specialty StoresRetail Trade Part of William Demant Fonden, WDH Germany GmbH is a company that engages in retailing hearing aids. The company is based in Hamburg, Germany. The CEOs are René Schneider, Arne Boye Nielsen, Søren Nielsen. The company was founded in 2008. | Specialty Stores | Chairman Chief Executive Officer | |
| ALK-ABELLÓ A/S | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| VIROGATES A/S | Medical Specialties | Director/Board Member Chief Executive Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| TDC A/S | Major Telecommunications | Human Resources Officer Chief Operating Officer | |
| NNIT A/S | Information Technology Services | Corporate Officer/Principal Corporate Officer/Principal | |
| MONSENSO A/S | Internet Software/Services | Chief Executive Officer Founder | |
Novozymes BioloAg A/S
 Novozymes BioloAg A/S BiotechnologyHealth Technology Novozymes BioloAg A/S provides research and development for biotechnology products and processes. It participates in The BioAg Alliance to commercialize BioAg assets and competencies within microbial research, development, and production. The company was founded on October 22, 2007 and is headquartered in Bagsvaerd, Denmark. | Biotechnology | Chief Executive Officer Director/Board Member | |
Novozymes Biopharma DK A/S
 Novozymes Biopharma DK A/S Pharmaceuticals: MajorHealth Technology Novozymes Biopharma DK A/S engages in the wholesale of pharmaceuticals and medical article. The firm operates and invests in research, development, production, and trade in biological solutions, including pharmaceuticals, and biotechnology products and processes.The company was founded on May 29, 2006 and is headquartered in Bagsvaerd, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biosyntia ApS
 Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member | |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director/Board Member | |
| AAC TECHNOLOGIES HOLDINGS INC. | Electronic Production Equipment | Chairman | |
| Microsoft Advanced Technology Center | Chief Executive Officer | ||
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Microsoft Research Asia | Corporate Officer/Principal | ||
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Affinicon ApS
 Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | Pharmaceuticals: Major | Chairman | |
Advanced MR Analytics AB
 Advanced MR Analytics AB Medical SpecialtiesHealth Technology Advanced MR Analytics AB offers solutions for body composition analysis. It transforms subjective magnetic resonance images into fat and muscle measurements. The firm provides technical research such as data acquisition and reconstruction; registration and fusion; machine learning and signal representation; modelling and simulation; simulation, classification, and quantification; visualization and image enhancement; and user interfaces and interaction. The company was founded by David Magnus Borga and Olof Erik Gunnar Dahlqvist Leinhard in 2010 and is headquartered in Link?ping, Sweden. | Medical Specialties | Director/Board Member | |
| Hewlett-Packard Laboratories | Corporate Officer/Principal | ||
| XPENG INC. | Motor Vehicles | Director/Board Member | |
| The Carlyle Group LP (Ireland) | Investment Managers | Consultant / Advisor | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member | |
Beijing Source Code Capital Co. Ltd.
 Beijing Source Code Capital Co. Ltd. Investment ManagersFinance Beijing Source Code Capital Co. Ltd (Beijing Source Code) is an independent private equity firm founded in 2014 by Cao Yi. The firm is headquartered in Beijing, China. | Investment Managers | Private Equity Investor | |
| Huami | Director/Board Member | ||
Ironfire Ventures
 Ironfire Ventures Investment ManagersFinance Ironfire Ventures (Ironfire Ventures) is a venture capital subsidiary of Ironfire Capital LLC founded in 2012 by Eric Jackson and Richard Chan. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Director of Investments | |
| Beijing Academy of Artificial Intelligence | Chairman | ||
Livingston International, Inc.
 Livingston International, Inc. Air Freight/CouriersTransportation Livingston International, Inc. engages in provision of customs brokerage, transportation and integrated logistics services. Its services include customs brokerage, U.S. customs brokerage, Canadian customs brokerage, Mexican customs brokerage, freight and transportation, global trade management, trade consulting, trade technology, business process services, trade sphere and vehicle transportation services. The company was founded by Gerry Livingston in 1945 and is headquartered in Toronto, Canada. | Air Freight/Couriers | Director/Board Member | |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Danemark | 31 |
| Chine | 8 |
| Etats-Unis | 5 |
| Suède | 4 |
| France | 2 |
Sectorielle
| Health Technology | 18 |
| Finance | 8 |
| Commercial Services | 6 |
| Consumer Services | 4 |
| Consumer Durables | 3 |
Opérationnelle
| Director/Board Member | 271 |
| Corporate Officer/Principal | 137 |
| Chief Executive Officer | 65 |
| Chairman | 61 |
| Independent Dir/Board Member | 47 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Anders Hove | 31 |
| Henrik Enegaard Skaanderup | 28 |
| Hong Jiang Zhang | 25 |
| Eva Berneke | 25 |
| Niels Bjørn Christiansen | 24 |
| Søren Møller | 21 |
| Christina Sørensen | 19 |
| Casper Breum | 18 |
| Søren Nielsen | 17 |
| Thomas Videbaek | 16 |
| Thomas Kähler | 16 |
| Helgi Gunnarsson | 15 |
| Ming Gao Ou Yang | 14 |
| Christoffer Leif Feilberg | 13 |
- Bourse
- Insiders
- Charlotte Dyring
- Connexions Sociétés
